Bindu Santhamma

753 total citations
22 papers, 456 citations indexed

About

Bindu Santhamma is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Bindu Santhamma has authored 22 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Bindu Santhamma's work include Estrogen and related hormone effects (7 papers), Cytokine Signaling Pathways and Interactions (6 papers) and HER2/EGFR in Cancer Research (3 papers). Bindu Santhamma is often cited by papers focused on Estrogen and related hormone effects (7 papers), Cytokine Signaling Pathways and Interactions (6 papers) and HER2/EGFR in Cancer Research (3 papers). Bindu Santhamma collaborates with scholars based in United States, Germany and China. Bindu Santhamma's co-authors include Robert M. Coates, Yuxin Zhao, Rodney Croteau, David C. Hyatt, BuHyun Youn, ChulHee Kang, Joseph K. Agyin, Rajeshwar R. Tekmal, Sudipa Saha Roy and Klaus Nickisch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Bindu Santhamma

18 papers receiving 452 citations

Peers

Countries citing papers authored by Bindu Santhamma

Since Specialization

Citations

This map shows the geographic impact of Bindu Santhamma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bindu Santhamma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bindu Santhamma more than expected).

Fields of papers citing papers by Bindu Santhamma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bindu Santhamma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bindu Santhamma. The network helps show where Bindu Santhamma may publish in the future.

Co-authorship network of co-authors of Bindu Santhamma

This figure shows the co-authorship network connecting the top 25 collaborators of Bindu Santhamma. A scholar is included among the top collaborators of Bindu Santhamma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bindu Santhamma. Bindu Santhamma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis 2025 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), Behnam Ebrahimi, Bindu Santhamma, Uday P. Pratap, Panneerdoss Subbarayalu, (unknown), Christoforos Thomas, Hareesh B. Nair, Ratna K. Vadlamudi, Suryavathi Viswanadhapalli	0
2	Significance of LIF/LIFR Signaling in the Progression of Obesity-Driven Triple-Negative Breast Cancer 2024 ·Cancers ·(unknown), (unknown), (unknown), Uday P. Pratap, (unknown), Yidong Chen, Zhao Lai, Bindu Santhamma, Edward R. Kost, (unknown), Ratna K. Vadlamudi, Panneerdoss Subbarayalu, Suryavathi Viswanadhapalli	0
3	The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling 2023 ·International Journal of Molecular Sciences ·Nicole Spencer, (unknown), (unknown), Panneerdoss Subbarayalu, (unknown), (unknown), (unknown), (unknown), (unknown), Bindu Santhamma, Manjeet K. Rao, Rajeshwar R. Tekmal, Hareesh B. Nair, Edward R. Kost, Ratna K. Vadlamudi, Suryavathi Viswanadhapalli	8
4	Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth 2022 ·Cancers ·(unknown), Uday P. Pratap, Xue Yang, Zexuan Liu, (unknown), Bindu Santhamma, Kumaraguruparan Ramasamy, (unknown), Yidong Chen, Zhao Lai, Siyuan Zheng, Gangadhara R. Sareddy, Philip T. Valente, Edward R. Kost, Hareesh B. Nair, Rajeshwar R. Tekmal, Ratna K. Vadlamudi, Suryavathi Viswanadhapalli	3
5	LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer 2021 ·Cell Death Discovery ·Weiwei Tang, Kumaraguruparan Ramasamy, (unknown), Bindu Santhamma, (unknown), Prabhakar Pitta Venkata, (unknown), Junhao Liu, Zexuan Liu, (unknown), Behnam Ebrahimi, Uday P. Pratap, Xiao‐Nan Li, Philip T. Valente, Edward R. Kost, Gangadhara R. Sareddy, Ratna K. Vadlamudi, (unknown), Rajeshwar R. Tekmal, Suryavathi Viswanadhapalli	19
6	EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model 2019 ·Scientific Reports ·Hareesh B. Nair, Bindu Santhamma, K.V. Dileep, Peter Binkley, (unknown), Kam Y. J. Zhang, Robert S. Schenken, Klaus Nickisch	5
7	Esters of levonorgestrel and etonogestrel intended as single, subcutaneous-injection, long-lasting contraceptives 2018 ·Steroids ·(unknown), (unknown), (unknown), Bindu Santhamma, Rajeshwar R. Tekmal, (unknown), (unknown), (unknown), Ze'ev Shaked, Klaus Nickisch	3
8	Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma 2018 ·Genes & Cancer ·Bradley R. Hall, Andrew Cannon, Christopher M. Thompson, Bindu Santhamma, (unknown), Rakesh Bhatia, (unknown), Klaus Nickisch, Surinder K. Batra, Sushil Kumar	20
9	Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo 2016 ·PLoS ONE ·Hareesh B. Nair, Bindu Santhamma, Naveen K. Krishnegowda, (unknown), Klaus Nickisch	3
10	Estradiol prodrugs (EP) for efficient oral estrogen treatment and abolished effects on estrogen modulated liver functions 2016 ·The Journal of Steroid Biochemistry and Molecular Biology ·W. Elger, Ralf Wyrwa, (unknown), (unknown), Hareesh B. Nair, Bindu Santhamma, (unknown), Birgitt Schneider, Reinhard Meister, Harald Schubert, Klaus Nickisch	6
11	Abstract LB-208: First-in-class steroidal leukemia inhibitory factor (LIF) inhibitor in targeted cancer therapy 2016 ·Cancer Research ·(unknown), Bindu Santhamma, (unknown), Klaus Nickisch	0
12	Discovery and preclinical pharmacology of EC330: A first-in-class leukemia inhibitory factor (LIF) inhibitor 2016 ·European Journal of Cancer ·(unknown), Bindu Santhamma, Suryavathi Viswanadhapalli, Gangadhara R. Sareddy, Vijaya L. Manthati, Ratna K. Vadlamudi, Klaus Nickisch	2
13	A new approach towards the synthesis of drospirenone and steroidal spirolactones 2015 ·Steroids ·Bindu Santhamma, (unknown), (unknown), Klaus Nickisch	6
14	Synthesis and biological evaluation of 11′ imidazolyl antiprogestins and mesoprogestins 2014 ·Steroids ·Klaus Nickisch, W. Elger, Bindu Santhamma, Robert E. Garfield, (unknown), (unknown), Birgitt Schneider, Reinhard Meister	5
15	Effects of a novel proteasome inhibitor BU-32 on multiple myeloma cells 2014 ·Cancer Chemotherapy and Pharmacology ·Sudipa Saha Roy, Nameer B. Kirma, Bindu Santhamma, Rajeshwar R. Tekmal, Joseph K. Agyin	9
16	Design, synthesis, and biological evaluation of bone-targeted proteasome inhibitors for multiple myeloma 2013 ·Bioorganic & Medicinal Chemistry Letters ·Joseph K. Agyin, Bindu Santhamma, Sudipa Saha Roy	21
17	Extranuclear Functions of ER Impact Invasive Migration and Metastasis by Breast Cancer Cells 2010 ·Cancer Research ·Dimple Chakravarty, Sujit S. Nair, Bindu Santhamma, Binoj C. Nair, (unknown), Abhik Bandyopadhyay, Joseph K. Agyin, Darrell W. Brann, Lu‐Zhe Sun, I‐Tien Yeh, Francis Y. Lee, Rajeshwar R. Tekmal, Rakesh Kumar, Ratna K. Vadlamudi	76
18	Hydroquinoid Chromium Complexes Bearing an Acyclic Conjugated Bridge: Chromium-Templated Synthesis, Molecular Structure, and Haptotropic Metal Migration 2010 ·Organometallics ·(unknown), Bindu Santhamma, Gregor Schnakenburg, Roland Fröhlich, Olga Kataeva, Martin Nieger, Konstantinos Kotsis, Frank Neese, Karl Heinz Dötz	7
19	Structure of limonene synthase, a simple model for terpenoid cyclase catalysis 2007 ·Proceedings of the National Academy of Sciences ·David C. Hyatt, BuHyun Youn, Yuxin Zhao, Bindu Santhamma, Robert M. Coates, Rodney Croteau, ChulHee Kang	195
20	Inhibition of monoterpene cyclases by inert analogues of geranyl diphosphate and linalyl diphosphate 2007 ·Archives of Biochemistry and Biophysics ·Frank Karp, Yuxin Zhao, Bindu Santhamma, (unknown), Robert M. Coates, Rodney Croteau	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact